Stay updated on Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added UI revision tag 'Revision: v3.5.2' and removed 'Revision: v3.5.0'.
    Difference
    0.1%
    Check dated 2026-04-16T10:23:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a new Publications entry: Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial (Blood, 2026).
    Difference
    0.1%
    Check dated 2026-04-09T07:55:23.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:34:00.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:18:55.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the older funding-notice (Revision: v3.4.1); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T06:24:32.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A site-wide funding notice and a page revision indicator (v3.4.1) were added; these do not modify the study's content or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:11:04.000Z thumbnail image

Stay in the know with updates to Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.